David M. Goldstein - Jun 27, 2024 Form 3 Insider Report for ALUMIS INC. (ALMS)

Role
Chief Scientific Officer
Signature
/s/ Sara Klein, Attorney-in-Fact
Stock symbol
ALMS
Transactions as of
Jun 27, 2024
Transactions value $
$0
Form type
3
Date filed
6/27/2024, 04:05 PM
Next filing
Jul 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ALMS Class A Common Stock 214K Jun 27, 2024 By Trust F1
holding ALMS Class A Common Stock 2.99K Jun 27, 2024 By Family Members F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ALMS Stock Option (Right to Buy) Jun 27, 2024 Class A Common Stock 42.8K $8.84 Direct F3
holding ALMS Stock Option (Right to Buy) Jun 27, 2024 Class A Common Stock 171K $8.84 Direct F4
holding ALMS Stock Option (Right to Buy) Jun 27, 2024 Class A Common Stock 12K $8.84 Direct F5
holding ALMS Stock Option (Right to Buy) Jun 27, 2024 Class A Common Stock 30.6K $8.84 Direct F6
holding ALMS Stock Option (Right to Buy) Jun 27, 2024 Class A Common Stock 206K $10.20 Direct F7
holding ALMS Stock Option (Right to Buy) Jun 27, 2024 Class A Common Stock 53.5K $13.33 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares are held directly by the Baily Goldstein Living Trust dated March 4, 2014, for which the Reporting Person serves as a trustee.
F2 Shares are held directly by family members of Reporting Person residing in his primary residence.
F3 25% of the shares underlying this option vested on January 27, 2023, and the remaining shares vest in equal monthly installments thereafter over the following 36 months, subject to acceleration and the Reporting Person's continuous service to the Issuer on each such vesting date.
F4 33% of the shares underlying this option vested on January 27, 2024, and the remaining shares vest in equal monthly installments thereafter over the following 48 months, subject to acceleration and the Reporting Person's continuous service to the Issuer on each such vesting date.
F5 25% of the shares underlying this option vested on May 22, 2024, and the remaining shares vest in equal monthly installments thereafter over the following 36 months, subject to acceleration and the Reporting Person's continuous service to the Issuer on each such vesting date.
F6 25% of the shares underlying this option vest on October 9, 2024, and the remaining shares vest in equal monthly installments thereafter over the following 36 months, subject to acceleration and the Reporting Person's continuous service to the Issuer on each such vesting date.
F7 The option vests in three equal installments, subject to the Issuer's satisfaction of certain performance criteria on each of May 6, 2028, May 6, 2029 and May 6, 2030, and subject to acceleration and the Reporting Person's continuous service to the Issuer on each such vesting date.
F8 25% of the shares underlying this option vest on June 6, 2025, and the remaining shares vest in equal monthly installments thereafter over the following 36 months, subject to acceleration and the Reporting Person's continuous service to the Issuer on each such vesting date.